SCHEMBL8107515

SCHEMBL8107515

[CH2]c1cccc(/C=C/c2ccc3ccccc3n2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYSLTR2 Q9NS75 6/20 0.70
CYSLTR1 Q9Y271 6/20 0.70
RAB9A P51151 8/20 0.70
NPC1 O15118 7/20 0.70
KDM4E B2RXH2 6/20 0.70
LMNA P02545 3/20 0.70
PKM P14618 2/20 0.70
MAPT P10636 5/20 0.58
L3MBTL1 Q9Y468 4/20 0.58
SMN1; SMN2 Q16637 4/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
ALDH1A1 P00352 2/20 0.58
GLA P06280 2/20 0.57
TDP1 Q9NUW8 2/20 0.54
MAPK1 P28482 2/20 0.54
RXFP1 Q9HBX9 1/20 0.54
HTT P42858 1/20 0.51
ECE2 P0DPD6 2/20 0.50
NFKB1 P19838 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8107518 1.00 CYSLTR2 (0.70) CYSLTR2CYSLTR1RAB9ANPC1KDM4E
SCHEMBL6759175 0.83 RAB9A (0.74) CYSLTR2CYSLTR1RAB9ANPC1KDM4E
SCHEMBL8303664 0.83 CYSLTR1 (0.55) CYSLTR2CYSLTR1RAB9ANPC1KDM4E
SCHEMBL8303662 0.83 CYSLTR1 (0.55) CYSLTR2CYSLTR1RAB9ANPC1KDM4E
SCHEMBL12884278 0.83 RAB9A (0.73) CYSLTR2CYSLTR1RAB9ANPC1KDM4E
SCHEMBL659665 0.83 RAB9A (1.00) CYSLTR2CYSLTR1RAB9ANPC1KDM4E
SCHEMBL30708719 0.83 RAB9A (1.00) CYSLTR2CYSLTR1RAB9ANPC1KDM4E
SCHEMBL659666 0.83 RAB9A (1.00) CYSLTR2CYSLTR1RAB9ANPC1KDM4E
SCHEMBL6796716 0.83 CYSLTR2 (0.68) CYSLTR2CYSLTR1RAB9ANPC1KDM4E
SCHEMBL6796712 0.83 CYSLTR2 (0.68) CYSLTR2CYSLTR1RAB9ANPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6121286-A ANTILEUKOTRIENE ACTIVITY AND ANTIHISTAMINIC ACTIVITY, FOR TREATING ASTHMA; COMPOUNDS SUCH AS 6-METHOXY-3-(2-(3-(2-QUINOLYLMETHOXY)BENZYL)TETRAZOLYL)QUINOLIN-2-ONE KOWA CO., LTD. (JP) 2000-09-19 US disclosed
US-6117886-A EXCELLENT ANTILEUKOTRIENE ACTIVITY AND ANTIHISTAMINIC ACTIVITY, AND IS USEFUL FOR THE PREVENTION AND TREATMENT OF, FOR EXAMPLE, ASTHMA. KOWA CO., LTD. (JP) 2000-09-12 US disclosed
EP-0469833-B1 N-Benzyl-Indoles, processes for their preparation and pharmaceutical compositions containing them LILLY CO ELI (GB) 1999-09-08 EP disclosed
CN-1040108-C Pharmaceutical compounds LILLY INDUSTRIES LTD (GB) 1998-10-07 CN disclosed
CN-1061413-A Medicinal compound LILLY INDUSTRIES LTD (GB) 1992-05-27 CN disclosed
EP-0469833-A1 N-Benzyl-Indoles, processes for their preparation and pharmaceutical compositions containing them LILLY INDUSTRIES LIMITED (GB) 1992-02-05 EP disclosed